MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 357 filers reported holding MEDIVATION INC in Q4 2015. The put-call ratio across all filers is 0.48 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $4,167,000 | +33.9% | 69,110 | +2.1% | 0.01% | +25.0% |
| Q1 2016 | $3,112,000 | -7.2% | 67,688 | -2.5% | 0.01% | 0.0% |
| Q4 2015 | $3,354,000 | -22.5% | 69,392 | -31.9% | 0.01% | -27.3% |
| Q3 2015 | $4,329,000 | -94.6% | 101,870 | -85.5% | 0.01% | -94.0% |
| Q2 2015 | $80,195,000 | -12.9% | 702,234 | -1.5% | 0.18% | -9.8% |
| Q1 2015 | $92,061,000 | +74.6% | 713,260 | +34.8% | 0.20% | +74.4% |
| Q4 2014 | $52,725,000 | +39.8% | 529,313 | +38.8% | 0.12% | +37.6% |
| Q3 2014 | $37,708,000 | +1148.2% | 381,385 | +873.1% | 0.08% | +1114.3% |
| Q2 2014 | $3,021,000 | -0.2% | 39,194 | -16.7% | 0.01% | 0.0% |
| Q1 2014 | $3,028,000 | +1.4% | 47,040 | +0.6% | 0.01% | 0.0% |
| Q4 2013 | $2,985,000 | +3.9% | 46,778 | -2.5% | 0.01% | 0.0% |
| Q3 2013 | $2,874,000 | +21.6% | 47,954 | -0.2% | 0.01% | 0.0% |
| Q2 2013 | $2,363,000 | – | 48,042 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,504,101 | $123,202,000 | 84.26% |
| BB BIOTECH AG | 1,449,706 | $71,326,000 | 5.14% |
| SECTORAL ASSET MANAGEMENT INC | 2,717,173 | $133,685,000 | 3.95% |
| PFM Health Sciences, LP | 2,417,306 | $118,931,000 | 2.47% |
| Bain Capital Public Equity Management, LLC | 2,127,075 | $104,652,000 | 2.45% |
| Partner Investment Management, L.P. | 205,257 | $10,099,000 | 2.28% |
| TRAXIS PARTNERS LP | 60,000 | $2,952,000 | 2.28% |
| HealthCor Management, L.P. | 650,000 | $31,980,000 | 1.93% |
| Loeb Offshore Management LP | 73,825 | $3,632,000 | 1.86% |
| QVT Financial LP | 547,628 | $26,943,000 | 1.81% |